SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Receptos, Inc.
20 Luglio 2015 - 12:35PM
Business Wire
Law office of Brodsky & Smith, LLC announces that it is
investigating potential claims against the Board of Directors of
Receptos, Inc. ("Receptos” or "the Company") (Nasdaq: RCPT) for
possible breaches of fiduciary duty and other violations of state
law in connection with the sale of the Company to Celgene
Corporation (“Celgene”).
Click here to learn more about the investigation
http://brodsky-smith.com/964-rcpt-receptos-inc.html, or call:
877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction, Receptos shareholders will
receive only $232.00 in cash for each share of Receptos stock they
own. The investigation concerns whether the Board of Receptos
breached their fiduciary duties to shareholders and whether Celgene
is underpaying for Receptos. The transaction may undervalue the
Company given Receptos has a strong pipeline which includes drug
candidates for ulcerative colitis, Cohn’s disease, relapsing
multiple sclerosis, inflammatory bowel disease, and eosinophilic
esophagitis. Consequently, an analyst has set a price target for
Receptos stock at $348.00 per share.
If you own shares of Receptos and wish to discuss the legal
ramifications of the investigation, or have any questions, you may
e-mail or call the law office of Brodsky & Smith, LLC who will,
without obligation or cost to you, attempt to answer your
questions. You may contact Jason L. Brodsky, Esquire or Evan J.
Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite
510, Bala Cynwyd, PA 19004, by visiting
http://brodsky-smith.com/964-rcpt-receptos-inc.html, or calling
toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive
expertise representing shareholders throughout the nation in
securities and class action lawsuits. The attorneys at Brodsky
& Smith have been appointed by numerous courts throughout the
country to serve as lead counsel in class actions and have
successfully recovered millions of dollars for our clients and
shareholders. Attorney advertising. Prior results do not guarantee
a similar outcome.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150720005180/en/
Brodsky & Smith, LLCJason L. Brodsky, EsquireEvan J. Smith,
Esquire877-LEGAL-90http://brodsky-smith.com/964-rcpt-receptos-inc.html
Grafico Azioni RECEPTOS, INC. (NASDAQ:RCPT)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni RECEPTOS, INC. (NASDAQ:RCPT)
Storico
Da Giu 2023 a Giu 2024